HUTCHISON CHINA MEDITECH LTD shareholders Q2 2023

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 68 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q2 2023. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

HUTCHISON CHINA MEDITECH LTD shareholders Q2 2023
NameSharesValueWeighting ↓
Renaissance Technologies 55,452$6650.00%
Baillie Gifford 142,475$1,709,7000.00%
GOLDMAN SACHS GROUP INC 542,683$6,512,1960.00%
MARSHALL WACE, LLP 40,970$491,6400.00%
Rathbones Group PLC 10,450$125,4000.00%
FIL Ltd 49,894$598,7280.00%
JANE STREET GROUP, LLC 300,381$3,604,5720.00%
Squarepoint Ops LLC 14,236$170,8320.00%
Bridgewater Associates 11,871$142,4520.00%
AMERIPRISE FINANCIAL INC 17,421$209,0520.00%
DEUTSCHE BANK AG\ 8,822$105,8640.00%
Amundi 36,901$437,2770.00%
CITIGROUP INC 2,113$25,3560.00%
VAN ECK ASSOCIATES CORP 550$70.00%
MORGAN STANLEY 43,426$521,1120.00%
BlackRock Inc. 99,138$1,189,6560.00%
Zurcher Kantonalbank (Zurich Cantonalbank) 1,317$15,8040.00%
ENVESTNET ASSET MANAGEMENT INC 15,401$184,8120.00%
Citadel Advisors 3,400$40,8000.00%
Citadel Advisors 2,000$24,0000.00%
External links

This page lists HUTCHISON CHINA MEDITECH LTD's shareholders in Q2 2023. To view HUTCHISON CHINA MEDITECH LTD's shareholder history, click here.